rs1555162486
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_006009.4(TUBA1A):c.283G>T(p.Gly95Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_006009.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBA1A | NM_006009.4 | c.283G>T | p.Gly95Cys | missense_variant | Exon 3 of 4 | ENST00000301071.12 | NP_006000.2 | |
TUBA1A | NM_001270399.2 | c.283G>T | p.Gly95Cys | missense_variant | Exon 3 of 4 | NP_001257328.1 | ||
TUBA1A | NM_001270400.2 | c.178G>T | p.Gly60Cys | missense_variant | Exon 3 of 4 | NP_001257329.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 48
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.283G>T (p.G95C) alteration is located in exon 3 (coding exon 3) of the TUBA1A gene. This alteration results from a G to T substitution at nucleotide position 283, causing the glycine (G) at amino acid position 95 to be replaced by a cysteine (C). The alteration is not observed in healthy cohorts:_x000D_ Based on data from the NHLBI Exome Sequencing Project (ESP), the TUBA1A c.283G>T alteration was not observed among 6,477 individuals tested. Allele frequency data for this nucleotide position are not currently available from the 1000 Genomes Project and the alteration is not currently listed in the Database of Single Nucleotide Polymorphisms (dbSNP). Though some variants may appear to be rare due to database-specific ethnic underrepresentation, rare missense alleles commonly exhibit a deleterious effect on protein function (Kryukov, 2007; Tennessen, 2012). IF USED, PULL THESE INTO REFERENCES:_x000D_ Kryukov GV, et al. (2007) Am J Hum Genet 80:727-739. Tennessen JA, et al. (2012) Science 337(64):64-69. The altered nucleotide is conserved throughout evolution:_x000D_ The c.283G nucleotide is completely conserved in available vertebrate species._x000D_ The altered amino acid is conserved throughout evolution:_x000D_ The p.G95 amino acid is completely conserved in available vertebrate species. The c.283G>T (p.G95C) alteration is located in coding exon 3 of the TUBA1A gene. The alteration consists of a G to T substitution at nucleotide position 283, causing the Glycine (G) at amino acid position 95 to be replaced by a Cysteine (C). The alteration is predicted deleterious by in silico models:_x000D_ The p.G95C alteration is predicted to be probably damaging by Polyphen and deleterious by SIFT in silico analyses._x000D_ The alteration is predicted not to affect splicing by in silico models:_x000D_ Based on BDGP and ESEfinder splice site in silico tools, this alteration does not have any significant effect on the native acceptor/donor splice site; however, direct evidence is unavailable Based on the available evidence, this alteration is classified as pathogenic. -
Tubulinopathy Pathogenic:1
A variant that is classified as pathogenic has been identified in the TUBA1A gene in a born individual of unknown sex. The c.283G>T, p.(Gly95Cys) variant has been reported as a variant of de novo origin. This variant and associated phenotype was previously reported by Helbig et al. Genet Med, 2016 HPO-standardized clinical features were: Generalized tonic-clonic seizures (HP:0002069) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at